DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Teraoka Y, Uchida T, Imamura M. , et al; Hiroshima Liver Study Group.
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice.
Biochem Biophys Res Commun 2018;
500 (02) 152-157
We do not assume any responsibility for the contents of the web pages of other providers.